Min T, Prior SL, Churm R, Dunseath G, Barry JD, Stephens JW
These impacts include anti-inflammatory effects, reduced amyloid-beta (A) deposition, reduced tau protein hyperphosphorylation, and improved insulin signaling (Calsolaro and Edison, 2016
While consensus does not exist regarding the exact synergistic mechanisms by which dual-agonists work, the addition of GIP agonism is posited to improve the HbA1c control and weight loss offered by GLP-1 agonists alone by enhancing insulin secretion, decreasing energy consumption, and stimulating satiety in the hypothalamus
, , ,
Food and Drug Administration approved its 25 mg oral Wegovy weight-loss pillthe first FDA-approved oral GLP-1 therapy for chronic weight management in adults
In addition, it has been described that oxidized cardiolipin modulates the biophysical properties of OMM to allow oligomerized Bax to insert and permeabilize the OMM (Mari et al., 2008